Plasma hsa-mir-19b is a potential LevoDopa therapy marker.
Chis AR, Moatar AI, Dijmarescu C, Rosca C, Vorovenci RJ, Krabbendam I, Dolga A, Bejinar C, Marian C, Sirbu IO, Simu M.
Chis AR, et al. Among authors: sirbu io.
J Cell Mol Med. 2021 Sep;25(18):8715-8724. doi: 10.1111/jcmm.16827. Epub 2021 Jul 30.
J Cell Mol Med. 2021.
PMID: 34328686
Free PMC article.